Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies

Human norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children <5 years. Mouse norovirus-infected macrophages are the most widely used in vitro system to screen and characterize the antiviral effect of norov...

Full description

Bibliographic Details
Main Authors: Jana Van Dycke, Jasper Rymenants, Johan Neyts, Joana Rocha-Pereira
Format: Article
Language:English
Published: SAGE Publishing 2021-09-01
Series:Antiviral Chemistry & Chemotherapy
Online Access:https://doi.org/10.1177/20402066211025175
id doaj-fbd8810ea0c74e17a0abc149299c24f0
record_format Article
spelling doaj-fbd8810ea0c74e17a0abc149299c24f02021-09-16T21:33:32ZengSAGE PublishingAntiviral Chemistry & Chemotherapy2040-20662021-09-012910.1177/20402066211025175Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studiesJana Van DyckeJasper RymenantsJohan NeytsJoana Rocha-PereiraHuman norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children <5 years. Mouse norovirus-infected macrophages are the most widely used in vitro system to screen and characterize the antiviral effect of norovirus-targeting small molecules. We have previously established antiviral assays using this system, identified novel inhibitors and performed additional studies in order to have a first insight into their mechanism of action. After the identification of novel small molecules with anti-norovirus activity (part 1 of this protocol), we here describe the logical next step which entails the generation of early information of their mode of action. This information together with a continuous improvement of the potency of compounds will contribute to the optimization of a compound class towards in vivo efficacy and a successful preclinical development.https://doi.org/10.1177/20402066211025175
collection DOAJ
language English
format Article
sources DOAJ
author Jana Van Dycke
Jasper Rymenants
Johan Neyts
Joana Rocha-Pereira
spellingShingle Jana Van Dycke
Jasper Rymenants
Johan Neyts
Joana Rocha-Pereira
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
Antiviral Chemistry & Chemotherapy
author_facet Jana Van Dycke
Jasper Rymenants
Johan Neyts
Joana Rocha-Pereira
author_sort Jana Van Dycke
title Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
title_short Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
title_full Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
title_fullStr Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
title_full_unstemmed Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
title_sort assessment of the anti-norovirus activity in cell culture using the mouse norovirus: early mechanistic studies
publisher SAGE Publishing
series Antiviral Chemistry & Chemotherapy
issn 2040-2066
publishDate 2021-09-01
description Human norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children <5 years. Mouse norovirus-infected macrophages are the most widely used in vitro system to screen and characterize the antiviral effect of norovirus-targeting small molecules. We have previously established antiviral assays using this system, identified novel inhibitors and performed additional studies in order to have a first insight into their mechanism of action. After the identification of novel small molecules with anti-norovirus activity (part 1 of this protocol), we here describe the logical next step which entails the generation of early information of their mode of action. This information together with a continuous improvement of the potency of compounds will contribute to the optimization of a compound class towards in vivo efficacy and a successful preclinical development.
url https://doi.org/10.1177/20402066211025175
work_keys_str_mv AT janavandycke assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies
AT jasperrymenants assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies
AT johanneyts assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies
AT joanarochapereira assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies
_version_ 1717377950275338240